Financhill
Back

Cullinan Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
29

CGEM
Cullinan Therapeutics

Last Price:
11.76
Seasonality Move:
28.88%
Sell
23

NBY
NovaBay Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-8.54%
Sell
29
Cullinan Therapeutics (CGEM) is a Sell

Is Cullinan Therapeutics a Buy, Sell or Hold?

  • The current Cullinan Therapeutics [CGEM] share price is $11.75. The Score for CGEM is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • CGEM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CGEM Stock Price Chart

What is Cullinan Therapeutics's stock price today?

  • The Cullinan Therapeutics share price today is $11.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGEM is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

CGEM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.77 Sell
Relative Strength Index (14 RSI): 32.7 Sell
Chaikin Money Flow: -156514 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.63 Sell
Chaikin Money Flow: 40319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.57 - 0.71) Sell
Bollinger Bands (100): (0.4 - 0.86) Sell

CGEM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.52 Sell
20-day SMA: 12.79 Sell
50-day SMA: 14.79 Sell
200-day SMA: 18.02 Sell
8-day EMA: 12.44 Sell
20-day EMA: 13.1 Sell
50-day EMA: 14.47 Sell
200-day EMA: 16.16 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Buy
20-day SMA: 0.62 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.67 Sell
200-day EMA: 4.92 Sell

Cullinan Therapeutics Earnings Growth & CGEM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and a decrease next year of $0.12 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Cullinan Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):